Article

Kaenon taps European partner

Kaenon Polarized announced a distribution partnership with optical manufacturer Rodenstock of Munich, Germany.

Newport Beach, CA-Kaenon Polarized announced a distribution partnership with optical manufacturer Rodenstock, of Munich, Germany.

Rodenstock will be the distribution partner of Kaenon Polarized products in the European Union, with an initial focus on Germany and Italy in 2010. Knitoptic Sarl will continue to operate as Kaenon's exclusive distribution partner in Switzerland.

"After 8 years of focused domestic distribution, this new distribution partnership . . . will allow both companies to leverage each other's success and strengths for the greater benefit of both," said Darren Rosenberg, chief operating officer and co-founder, Kaenon.

All of Kaenon's styles will continue to be available for prescription in Europe, featuring the benefits of the brand's polarized lenses (SR-91). Prescription sunglasses will be available in Kaenon's individually customized digitally surfaced Freestyle (Freeform) technology in both single vision and Freestyle progressive lenses.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.